Idris Abdullahi

Dr. Idris Abdullahi

Department of Pharmaceutical Chemistry, Kaduna State University, Kaduna, Nigeria
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2024 in UMYU Scientifica
Verified
Journal Article
Open access
PDF file
MHMariya Musa Hamza
Mariya Musa Hamza
YUYahaya Abdullahi Umar
Yahaya Abdullahi Umar
MAMohammed Sani Abdulsalami
Mohammed Sani Abdulsalami
GOGodwin Brian Onwumere
Godwin Brian Onwumere
Idris AbdullahiIdris Abdullahi
Idris Abdullahi
MSMansur Muhammad Shehu
Mansur Muhammad Shehu
Study’s Excerpt Full Abstract For decades, man has utilized plants as traditional medicine to cure various illnesses. The majority of modern medications now available have been generated from plants. This study subjected the ethanolic crude extract of Adansonia digitata stem bark, Morinda citrifolia leaves, and Tamarindus indica leaves to phytochemical analysis. Ultraviolet/visible spectrophotometric techniques were used to quantify the bioactive compounds detected in the plants. Qualitative analysis indicated the presence of alkaloids, cardiac glycosides, saponins, phenolic compounds, tannins, steroids, carbohydrates, flavonoids, terpenoids, reducing sugars, and quinones in all three plant extracts. Anthraquinones were detected only in A. digitata, while coumarins, though present in M. citrifolia and T. indica, were absent in A. digitata. Adansonia digitata recorded a higher content of anthraquinones (59.3 mg/g), phenols (79.3 mg/g), and tannins (286.1 mg/g) than M. citrifolia and T. indica. Alkaloids (45.5 mg/g), flavonoids (124.0 mg/g), saponins (38.7 mg/g), and triterpenes (23.8 mg/g) were found to be higher in T. indica than in A. digitata and M. citrifolia. Statistical analysis shows significant variation in the concentration of these compounds between the sampled plants (p < 0.05). The high bioactive content of A. digitata and T. indica indicates their potential as outstanding bioactive compound repositories suitable for drug development, purification, and functional food uses.

20 November 2025 in Chemistry Proceedings
Verified
Conference Paper
Open access
PDF file
AYAbubakar Sadiq Yakubu
Abubakar Sadiq Yakubu
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
IAIdris Yunusa Abdullahi
Idris Yunusa Abdullahi
MAmaryam abdullahi
maryam abdullahi
Idris AbdullahiIdris Abdullahi
Idris Abdullahi
IAIDRIS UMAR ALFULANII
IDRIS UMAR ALFULANII
Depression is a debilitating neuropsychiatric disorder and a leading cause of disability worldwide, with current therapeutic options often limited by delayed onset of action, inadequate efficacy, and undesirable side effects. The quinoline scaffold, a privileged structure in medicinal chemistry, has been reported to possess a wide spectrum of pharmacological properties, including central nervous system (CNS) modulation. In this study, two novel 2,4-diphenylquinoline derivatives—CMPD1 [2-(4-methoxyphenyl)-4-phenylquinoline] and CMPD2 [2-(2,4-dichlorophenyl)-4-phenylquinoline]—were rationally designed based on structure–activity relationship (SAR) insights and synthesized via the Friedländer condensation of appropriately substituted anilines with carbonyl precursors. Purification was achieved through recrystallization, and structural confirmation was performed using Fourier-transform infrared (FT-IR) spectroscopy, proton nuclear magnetic resonance (NMR), and carbon-13 NMR spectroscopy, confirming the expected chemical shifts and diagnostic signals for quinoline derivatives. The pharmacological activity was evaluated using murine models for antidepressant screening: the Forced Swim Test (FST) and Tail Suspension Test (TST). Both compounds produced statistically significant reductions in immobility time compared to the control group (p < 0.05), with CMPD2 showing slightly enhanced activity. The results suggest that electron-donating and electron-withdrawing substituents influence antidepressant potency, potentially through modulation of CNS receptor binding. These findings validate 2,4-diphenylquinoline derivatives as promising antidepressant leads, meriting further optimization, in vivo pharmacokinetic studies, and mechanistic investigations to establish their clinical translation potential.